Ascentage Pharma Group International (AAPG) Finished Goods (2023 - 2025)

Ascentage Pharma Group International (AAPG) has reported Finished Goods for 3 consecutive years, with $1.0 million the latest figure, recorded in Q4 2025.

• Quarterly Finished Goods rose 94.81% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (up 94.81% YoY) and the FY2025 annual result came in at $1.1 million, up 100.38% from the prior year.
• Finished Goods advanced to $1.0 million in Q4 2025 per AAPG's latest filing, from $537511.9 in the prior quarter.
• Over the last five years, Finished Goods for AAPG reached as high as $1.5 million in Q4 2023 and fell as low as $537511.9 in Q4 2024.
• A 3-year average of $1.0 million and a median of $1.0 million in 2025 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2024 — Finished Goods sank 65.06% — and 2025, when it soared 94.81%.
• Year by year, Finished Goods stood at $1.5 million in 2023, then plunged by 65.06% to $537511.9 in 2024, then soared by 94.81% to $1.0 million in 2025.
• According to Business Quant data, Finished Goods over the past three periods registered $1.0 million, $537511.9, and $1.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.